Midostaurin Reverses ABCB1-Mediated Multidrug Resistance, an in vitro Study.

Ji N, Yang Y, Cai CY, Wang JQ, Lei ZN, Wu ZX, Cui Q, Yang DH, Chen ZS, Kong D

DOI: 10.3389/fonc.2019.00514
Published: 2019
Container: Frontiers in oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2019.00514,
  title = {Midostaurin Reverses ABCB1-Mediated Multidrug Resistance, an in vitro Study.},
  author = {Ji N and Yang Y and Cai CY and Wang JQ and Lei ZN and Wu ZX and Cui Q and Yang DH and Chen ZS and Kong D},
  year = {2019},
  journal = {Frontiers in oncology},
  doi = {10.3389/fonc.2019.00514},
  url = {https://doi.org/10.3389/fonc.2019.00514}
}

RIS

TY  - JOUR
TI  - Midostaurin Reverses ABCB1-Mediated Multidrug Resistance, an in vitro Study.
AU  - Ji N
AU  - Yang Y
AU  - Cai CY
AU  - Wang JQ
AU  - Lei ZN
AU  - Wu ZX
AU  - Cui Q
AU  - Yang DH
AU  - Chen ZS
AU  - Kong D
PY  - 2019
JO  - Frontiers in oncology
DO  - 10.3389/fonc.2019.00514
UR  - https://doi.org/10.3389/fonc.2019.00514
ER  -

APA

N, J., Y, Y., CY, C., JQ, W., ZN, L., ZX, W., Q, C., DH, Y., ZS, C., & D, K. (2019). Midostaurin Reverses ABCB1-Mediated Multidrug Resistance, an in vitro Study.. Frontiers in oncology. https://doi.org/10.3389/fonc.2019.00514

Source records

pubmed · retrieved 2026-11-10T12:16:50.754Z